Snowball logo
logo
SAGE_logo

Sage Therapeutics, Inc

SAGE β€’ NASDAQ
$8.68$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
1,114.26.3087.68686.4541.2470.41
COGS
0.5650.5530.8132.1599.4447.367
Gross Profit
1,113.65.7556.87384.331.863.04
Operating Expenses & Income
Operating Income
596.2(460.9)(547)(579.8)(432.4)(324.8)
Total Operating Expenses
489.7466.7553.9630.8464.2387.9
R&D Expenses
292.7283.2326.2356.2225.9138.3
Selling General & Admin Expenses
197183.5227.7274.5216.4227.5
Earnings from Continuing Operations
Interest Expense
-(7.199)(14.19)---
Interest Income
9.5972.88314.1936.0731.6823.59
Income Tax Expense
15.52(7.065)(29.52)(5.357)(400.7)-
Net Income
Net Income
606.1(450.8)(503.3)(541.5)(400.7)(301.2)
Supplemental
EBIT
624(460.9)(547)(546.5)(410.5)(303.6)
EBITDA
626.6(456.7)(545.9)(545.1)(409.5)(303)
In millions of USD, except % and values per 1 share